PMC:7435837 / 42100-42219 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7435837","sourcedb":"PMC","sourceid":"7435837","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7435837","text":"s head-on. These include, for example, resistance to absorption of therapeutic agents into the body or degradation of t","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T269","span":{"begin":2,"end":6},"obj":"Body_part"},{"id":"T270","span":{"begin":95,"end":99},"obj":"Body_part"}],"attributes":[{"id":"A269","pred":"fma_id","subj":"T269","obj":"http://purl.org/sig/ont/fma/fma7154"},{"id":"A270","pred":"fma_id","subj":"T270","obj":"http://purl.org/sig/ont/fma/fma256135"},{"subj":"T269","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T270","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T23","span":{"begin":2,"end":6},"obj":"Body_part"}],"attributes":[{"id":"A23","pred":"uberon_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/UBERON_0000033"},{"subj":"T23","pred":"source","obj":"LitCovid-PD-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T394","span":{"begin":2,"end":6},"obj":"http://purl.obolibrary.org/obo/UBERON_0000033"},{"id":"T395","span":{"begin":2,"end":6},"obj":"http://www.ebi.ac.uk/efo/EFO_0000964"}],"attributes":[{"subj":"T394","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T395","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T33","span":{"begin":103,"end":114},"obj":"http://purl.obolibrary.org/obo/GO_0009056"}],"attributes":[{"subj":"T33","pred":"source","obj":"LitCovid-PD-GO-BP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#939cec","default":true},{"id":"LitCovid-PD-UBERON","color":"#b6ec93"},{"id":"LitCovid-PD-CLO","color":"#ec93d0"},{"id":"LitCovid-PD-GO-BP","color":"#93eaec"}]}]}}